Company Filing History:
2 out of 49 
1 out of 63 
1 out of 1,245 
Years Active: 2016-2025
Title: Innovations by Inventor JaeWon Lee in Pharmaceutical Development
Introduction
JaeWon Lee, an inventive researcher based in Yongin-si, South Korea, has made significant strides in the field of pharmaceutical innovation. With a total of two patents to his name, his work primarily focuses on developing novel compounds that exhibit therapeutic potential, particularly in the treatment of lymphoid malignancies and cholesterol regulation.
Latest Patents
JaeWon Lee's recent inventions showcase his commitment to advancing medical science. His latest patents include:
1. **N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drug**: This invention pertains to novel N-acylhydrazone derivatives that demonstrate selective inhibition of T cell activity and anti-lymphoid malignancy effects. The patent outlines their preparation, pharmaceutical compositions containing these derivatives, and the methodologies for their application in therapeutic treatments.
2. **Cycloalkenyl aryl derivatives for CETP inhibitor**: This patent describes cycloalkenyl aryl derivatives that inhibit CETP activity, which is crucial for managing cholesterol levels. The compounds developed by JaeWon Lee can potentially increase HDL-cholesterol while decreasing LDL-cholesterol, offering a promising avenue for cardiovascular health.
Career Highlights
Throughout his career, JaeWon Lee has collaborated with various institutions, enhancing his expertise in pharmaceutical research. He has worked with Chong Kun Dang Pharmaceutical Corporation, where he contributed to the development of significant medicinal compounds. Additionally, his association with Inje University Industry-Academic Cooperation Foundation allowed him to blend academic research with practical applications in the pharmaceutical sector.
Collaborations
In his journey as an inventor, JaeWon Lee has partnered with esteemed colleagues such as NiNa Ha and HoJin Choi. These collaborations have been instrumental in fostering innovative ideas and transforming them into applicable solutions in the medical field.
Conclusion
JaeWon Lee exemplifies the role of a modern inventor, bridging the gap between research and practical application. His patents signify not only a commitment to scientific innovation but also the potential to address critical health challenges. As the landscape of pharmaceutical development continues to evolve, JaeWon Lee's contributions are sure to make a lasting impact in the industry.